The Food and Drug Administration will hold a public meeting on July 12 to discuss foods produced using animal cell culture technology. National Cattlemen’s Beef Association (NCBA) Director of Government Affairs Danielle Beck issued the following statement in response to the announced meeting:
“NCBA looks forward to participating fully in the public meeting, and will use the opportunity to advocate for U.S. Department of Agriculture (USDA) oversight of lab-grown fake meat products. The Food and Drug Administration’s announcement disregards the authorities granted to USDA under the Federal Meat Inspection Act, as well as USDA’s significant scientific expertise and long-standing success in ensuring the safety of all meat and poultry products. Under the current regulatory framework, FDA plays an important role in terms of ensuring the safety of food additives used in meat, poultry, and egg products. All additives are initially evaluated for safety by FDA, but ultimately FSIS maintains primary jurisdiction.”
According to the FDA, the public meeting is intended to provide interested parties and the public with an opportunity to comment on emerging lab-grown protein technology. The public meeting is not a formal decision and will not prevent USDA from asserting primary jurisdiction.
NCBA says USDA oversight of lab-grown protein products is consistent with existing federal laws. Lab-grown protein products fall within statutory definitions of a meat byproduct. USDA is responsible for ensuring the safety and proper labeling of all such products under the Federal Meat Inspection Act (FMIA) and the Poultry Products Inspection Act (PPIA).